Ricky Goldwasser
Stock Analyst at Morgan Stanley
(2.15)
# 1162
Out of 5,235 analysts
335
Total ratings
57.32%
Success rate
16.93%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Labcorp Holdings | Maintains: Overweight | 260 270 | 235.09 | 14.85% | 15 | Dec 17, 2024 | |
Accolade | Maintains: Equal-Weight | 6 5 | 3.34 | 49.7% | 17 | Dec 17, 2024 | |
Doximity | Upgrades: Equal-Weight | 33 53 | 55.42 | -4.37% | 9 | Nov 14, 2024 | |
UnitedHealth Group | Maintains: Overweight | 615 610 | 514.03 | 18.67% | 15 | Oct 16, 2024 | |
LifeStance Health Gr | Reiterates: Overweight | 10 10 | 7.51 | 33.16% | 8 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 6 | 4.41 | 24.72% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 220 205 | 189.76 | 8.03% | 19 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 8 | 14.4 | -47.92% | 6 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 160 8 | n/a | n/a | 10 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 12 | 11.71 | 2.48% | 8 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 94 73 | 62.58 | 16.65% | 10 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 145 145 | 153.62 | -5.61% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 176 190 | n/a | n/a | 19 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 365 365 | 296.57 | 23.07% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 403 420 | n/a | n/a | 22 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 120 | 7.34 | 1534.88% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 10 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 549 620 | n/a | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 18 | n/a | n/a | 6 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 485 500 | 380.6 | 31.37% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 127 124 | 45.77 | 170.92% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 296 318 | 279.84 | 13.64% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 74 70 | 121.31 | -42.3% | 16 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 43 39 | 9.68 | 302.89% | 14 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 607 533 | n/a | n/a | 9 | Jun 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 24 14 | n/a | n/a | 6 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 85 95 | n/a | n/a | 11 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 25 | 28.85 | -13.34% | 1 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 115 135 | n/a | n/a | 8 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 14 18 | n/a | n/a | 6 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 182 195 | 202.79 | -3.84% | 6 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 89 91 | n/a | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 128 135 | n/a | n/a | 3 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 96 121 | n/a | n/a | 1 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | n/a | n/a | n/a | 1 | May 11, 2017 |